Xujuan Hu

5.6k total citations
9 papers, 68 citations indexed

About

Xujuan Hu is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Xujuan Hu has authored 9 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Xujuan Hu's work include Viral Infections and Immunology Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Xujuan Hu is often cited by papers focused on Viral Infections and Immunology Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Xujuan Hu collaborates with scholars based in China. Xujuan Hu's co-authors include Xiulian Sun, Zhèngyuán Sū, Fēi Dèng, Wuxiang Guan, Rongjuan Pei, Junji Cao, Chengfeng Lei, Jia Hu, Yu Huang and Zhe Chen and has published in prestigious journals such as Scientific Reports, Signal Transduction and Targeted Therapy and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Xujuan Hu

9 papers receiving 68 citations

Peers

Xujuan Hu

PRM

ID

MS

ONCOL

MB

Mariya Kalinova United Kingdom

Francisco Fanjul Spain

Helem Vílchez Spain

Xavier Charmetant France

Amin Khattab Saudi Arabia

Valentin Pointurier France

André Rebaza United States

Gaëtan Plantefève France

Jade Xiao United States

Dexiang Yang China

Mariya Kalinova United Kingdom

Xujuan Hu

24 ×0.8

PRM

39 ×1.3

ID

21 ×1.1

MS

6 ×0.5

ONCOL

6 ×0.7

MB

Citations per year, relative to Xujuan Hu Xujuan Hu (= 1×) peers Mariya Kalinova

Countries citing papers authored by Xujuan Hu

Since Specialization

Citations

This map shows the geographic impact of Xujuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xujuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xujuan Hu more than expected).

Fields of papers citing papers by Xujuan Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xujuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xujuan Hu. The network helps show where Xujuan Hu may publish in the future.

Co-authorship network of co-authors of Xujuan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xujuan Hu. A scholar is included among the top collaborators of Xujuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xujuan Hu. Xujuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Gong, Rui, Qian Wang, Xujuan Hu, et al.. (2025). Piplartine alleviates sepsis-induced acute kidney injury by inhibiting TSPO-mediated macrophage pyroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167687–167687. 2 indexed citations

2.

Wang, Qian, Ying Liu, Mingzhe Yan, et al.. (2024). Seasonal shifts in respiratory pathogen co-infections and the associated differential induction of cytokines in children. Cytokine. 186. 156847–156847. 1 indexed citations

3.

Wang, Dong, Han Yang, Chaolin Huang, et al.. (2024). FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection. Signal Transduction and Targeted Therapy. 9(1). 104–104. 4 indexed citations

4.

Huang, Chaolin, Xujuan Hu, Qiongya Wang, et al.. (2024). Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19. Scientific Reports. 14(1). 10324–10324. 7 indexed citations

5.

Wang, Qian, et al.. (2023). Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71. Antiviral Research. 211. 105553–105553. 6 indexed citations

6.

Yang, Qingyu, Xujuan Hu, Ke Peng, et al.. (2022). ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway. Antiviral Research. 209. 105498–105498. 5 indexed citations

7.

Han, Yang, Peipei Liu, Yang Qiu, et al.. (2021). Effective virus-neutralizing activities in antisera from the first wave of severe COVID-19 survivors. JCI Insight. 6(4). 9 indexed citations

8.

Hu, Jia, Chengfeng Lei, Zhen Chen, et al.. (2020). Airborne SARS-CoV-2 and the Use of Masks for Protection against Its Spread in Wuhan, China. 5 indexed citations

9.

Hu, Jia, Chengfeng Lei, Zhe Chen, et al.. (2020). Distribution of airborne SARS-CoV-2 and possible aerosol transmission in Wuhan hospitals, China. National Science Review. 7(12). 1865–1867. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact